So, Gilteritinib is this FLT3 inhibitor. It’s mainly used for treating AML that comes back or doesn’t respond to other treatments, especially if the leukemia has FLT3 mutations. How it works? It blocks this FLT3 kinase thing, and that slows down the growth of leukemia cells.
This drug comes as 40 mg tablets, with a special coating on them. You’re supposed to take 120 mg of it, just once a day, and by mouth. Each bottle holds 90 of these tablets.
